Načítá se...
Development of a central nervous system axonal myelination assay for high throughput screening
BACKGROUND: Regeneration of new myelin is impaired in persistent multiple sclerosis (MS) lesions, leaving neurons unable to function properly and subject to further degeneration. Current MS therapies attempt to ameliorate autoimmune-mediated demyelination, but none directly promote the regeneration...
Uloženo v:
| Vydáno v: | BMC Neurosci |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4840960/ https://ncbi.nlm.nih.gov/pubmed/27103572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12868-016-0250-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|